Compounds
TB Alliance is searching for new, faster-acting, and affordable treatments. The following list details compounds, approved TB drugs, and discovery projects that exist within one or more of TB Alliance’s research programs.
-
Evotec
-
-
-
University of Illinois at Chicago, Texas A&M University, Harvard University, Center of Excellence in Translational Research (CETR)
-
University of Illinois at Chicago, Harvard University, Center of Excellence in Translational Research (CETR)
-
University of Auckland, University of Illinois at Chicago
-
-
Daiichi Sankyo RD Novare
-
-
Chugai
-
-
Daiichi Sankyo RD Novare
-
Takeda Pharmaceuticals
-
Takeda Pharmaceuticals, University of Illinois at Chicago, Daiichi Sankyo RD Novare, Chugai, Astellas
-
Global Health Drug Discovery Institute
-
GlaxoSmithKline
-
Evotec
-
-
GlaxoSmithKline
-
-
Evotec
-
Texas A&M University
-
AbbVie, ERA4TB
-
-
Evotec
-
Bill & Melinda Gates Medical Research Institute
-
TropIQ, Weill Cornel Medical
-
Schrodinger, University of Auckland
-
Evotec, Texas A&M University, Weill Cornel Medical, University of North Carolina
-
Johns Hopkins University
-
-
-
Qurient Therapeutics
-
-
Center of Excellence in Translational Research (CETR)
-
Evotec
-
Bill & Melinda Gates Medical Research Institute
-
Foundation for Neglected Disease Research, Bill & Melinda Gates Medical Research Institute
-
ERA4TB
-
-
Institute of Materia Medica
-
GlaxoSmithKline